Bio Green Med Solution is trading 5.7% lower at $0.89, with the catalyst unclear. - No new company-specific announcement explaining the October 23 move was identified. - The latest located filing was an October 16 announcement of a preferred-stock dividend; it does not establish a cause for the decline. - The broader market is mixed, and the supplied consumer-staples sector context does not establish a direct connection to the company.